Outpatient parenteral antimicrobial therapy in pediatrics: An opportunity to expand antimicrobial stewardship

Infection Control and Hospital Epidemiology

Volumn 36, Issue 2, 2015, Pages 222-224

  Knackstedt, Elizabeth D ^a   Stockmann, Chris ^a   Davis, Carly R ^a   Thorell, Emily A ^a   Pavia, Andrew T ^a   Hersh, Adam L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM; CEFALEXIN; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CLINDAMYCIN; NAFCILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN; TAZOBACTAM; VANCOMYCIN;

ABDOMINAL INFECTION; ADOLESCENT; ANTIMICROBIAL THERAPY; APPENDIX PERFORATION; ARTICLE; BACTERIAL ARTHRITIS; CATHETER INFECTION; CHILD; CYSTIC FIBROSIS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HOME CARE; HOSPITAL DISCHARGE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PYELONEPHRITIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SPINAL CORD INFECTION; TRACHEITIS; TREATMENT OUTCOME; URINARY TRACT INFECTION; AMBULATORY CARE; BACTERIAL INFECTIONS; HOSPITAL; INFECTIOUS DISEASE MEDICINE; INTRAVENOUS DRUG ADMINISTRATION; PATIENT REFERRAL; STATISTICS AND NUMERICAL DATA; TERTIARY CARE CENTER; UTILIZATION;

ADMINISTRATION, INTRAVENOUS; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; HOME CARE SERVICES; HOSPITALS, PEDIATRIC; HUMANS; INFECTIOUS DISEASE MEDICINE; PATIENT DISCHARGE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 84922740097     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1017/ice.2014.27     Document Type: Article

References (10)

1. Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 1974;54:358-360.
2. Rathore MH. The unique issues of outpatient parenteral anti-microbial therapy in children and adolescents. Clin Infect Dis 2010;51:S209-S215.
3. Barrier A, Williams DJ, Connelly M, Creech CB. Frequency of peripherally inserted central catheter complications in children. Pediatr Infect Dis J 2012;31:519-521.
4. Conant MM, Erdman SM, Osterholzer D. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases. J Antimicrob Chemother 2014;69:1695-1700.
5. Heintz BH, Halilovic J, Christensen CL. Impact of a multi- disciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center. Ann Pharmacother 2011;45:1329-1337.
6. Sharma R, Loomis W, Brown RB. Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy. Am J Med Sci 2005;330:60-64.
7. Shrestha NK, Bhaskaran A, Scalera NM, Schmitt SK, Rehm SJ, Gordon SM. Antimicrobial stewardship at transition of care from hospital to community. Infect Control Hosp Epidemiol 2012; 33:401-404.
8. Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis 2004;38:1651-1672.
9. Banerjee R, Beekmann S, Doby E, Polgreen P, Rathore M, Hersh A. Outpatient parenteral antimicrobial therapy (OPAT) practices among pediatric infectious diseases consultants: results of an Emerging Infections Network survey. J Pediatric Infect Dis Soc 2014;3:85-88.
10. Madigan T, Banerjee R. Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children’s hospital. Pediatr Infect Dis J 2013;32:346-349.